Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the Unguided Online Program Ceprica for the Treatment of Migraine: a Double-blind Randomized Controlled Trial

NCT04276142 is registered in ClinicalTrials.gov with Gaia AG as lead sponsor.

NCT NCT04276142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the Unguided Online Program Ceprica for the Treatment of Migraine: a Double-blind Randomized Controlled Trial
Lead sponsor
Gaia AG
Phase
Not applicable
Overall status
Completed
Start date
June 5, 2023
Completion date
August 20, 2024
Enrollment
321 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine